Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans
S. Currie(Centre for Inflammation Research), Donald J. Davidson(Centre for Inflammation Research)
Cited by 138
Related Papers
Antimicrobial host defence peptides: functions and clinical potential
|Nature Reviews Drug Discovery|2020|1.4k
The Human Cathelicidin LL-37 Preferentially Promotes Apoptosis of Infected Airway Epithelium
|American Journal of Respiratory Cell and Molecular Biology|2010|112
Cathelicidin Host Defence Peptide Augments Clearance of Pulmonary Pseudomonas aeruginosa Infection by Its Influence on Neutrophil Function In Vivo
|PLoS ONE|2014|86
Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages
|Journal of Leukocyte Biology|2009|48